Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies.
Adib M, Peytam F, Shourgeshty R, Mohammadi-Khanaposhtani M, Jahani M, Imanparast S, Faramarzi MA, Larijani B, Moghadamnia AA, Esfahani EN, Bandarian F, Mahdavi M. Adib M, et al. Bioorg Med Chem Lett. 2019 Mar 1;29(5):713-718. doi: 10.1016/j.bmcl.2019.01.012. Epub 2019 Jan 14. Bioorg Med Chem Lett. 2019. PMID: 30661823
New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study.
Adib M, Peytam F, Rahmanian-Jazi M, Mahernia S, Bijanzadeh HR, Jahani M, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Mahdavi M, Larijani B. Adib M, et al. Eur J Med Chem. 2018 Jul 15;155:353-363. doi: 10.1016/j.ejmech.2018.05.046. Epub 2018 May 29. Eur J Med Chem. 2018. PMID: 29902721
Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes.
Mohammadi-Khanaposhtani M, Rezaei S, Khalifeh R, Imanparast S, Faramarzi MA, Bahadorikhalili S, Safavi M, Bandarian F, Nasli Esfahani E, Mahdavi M, Larijani B. Mohammadi-Khanaposhtani M, et al. Bioorg Chem. 2018 Oct;80:288-295. doi: 10.1016/j.bioorg.2018.06.035. Epub 2018 Jun 30. Bioorg Chem. 2018. PMID: 29980114
Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M, Mohammadi-Khanaposhtani M, Pourrabia P, Razzaghi N, Ghadimi R, Imanparast S, Faramarzi MA, Bandarian F, Esfahani EN, Safavi M, Rastegar H, Larijani B, Mahdavi M, Akbarzadeh T. Saeedi M, et al. Bioorg Chem. 2019 Mar;83:161-169. doi: 10.1016/j.bioorg.2018.10.023. Epub 2018 Oct 11. Bioorg Chem. 2019. PMID: 30366316
A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.
Nasli-Esfahani E, Mohammadi-Khanaposhtani M, Rezaei S, Sarrafi Y, Sharafi Z, Samadi N, Faramarzi MA, Bandarian F, Hamedifar H, Larijani B, Hajimiri M, Mahdavi M. Nasli-Esfahani E, et al. Arch Pharm (Weinheim). 2019 Aug;352(8):e1900034. doi: 10.1002/ardp.201900034. Epub 2019 Jul 22. Arch Pharm (Weinheim). 2019. PMID: 31330079
68 results